Table 3.
Outcome | N Studies | N PRP | PRP Mean | Control N | Control Mean | P-Value |
---|---|---|---|---|---|---|
FSS 1 Mo | 5 | 137 | 5.05 | 136 | 6.17 | 0.57 |
FSS 3 Mo | 6 | 158 | 4.59 | 156 | 5.95 | 0.03a |
FSS 6 Mo |
3 |
76 |
5.05 |
76 |
6.17 |
0.03a |
SSS 1 Mo | 5 | 137 | 7.52 | 136 | 8.46 | <0.00001a |
SSS 3 Mo | 6 | 158 | 7.97 | 156 | 8.14 | <0.00001a |
SSS 6 Mo |
3 |
158 |
6.64 |
156 |
7.58 |
0.23 |
VAS 1 Mo | 3 | 91 | 2.9 | 90 | 3.4 | 0.51 |
VAS 3 Mo | 5 | 138 | 2.9 | 134 | 3.5 | <0.0001a |
C; Control, FSS; Functional Status Scale, Mo; Month, N; Number, N/R; Not reported, PRP; Platelet-Rich Plasma, SSS; Symptomatic Severity, VAS; Visual Analogue Scale.
denotes statistical significance.